Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay

Clinical and Vaccine Immunology

Volumn 16, Issue 1, 2009, Pages 66-72

  Lange, C E ^a   Tobler, K ^a   Favrot, C ^a   Muller M ^b   Nothling J O ^c   Ackermann, M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CASEIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CANINE ORAL PAPILLOMAVIRUS; CANINE PAPILLOMAVIRUS 3; DISEASE PREDISPOSITION; DOG DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMODYSPLASIA VERRUCIFORMIS; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; SEROPREVALENCE; SERUM;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMODYSPLASIA VERRUCIFORMIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECOMBINANT FUSION PROTEINS; SEROEPIDEMIOLOGIC STUDIES; SOUTH AFRICA; SWITZERLAND;

EID: 58149376072     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00346-08     Document Type: Article

References (48)

1. Aaltonen, L. M., R. W. Chen, S. Roth, A. A. Makitie, H. Rihkanen, A. Vaheri, and L. A. Aaltonen. 2001. Role of TP53 P72R polymorphism in human papillomavirus associated premalignant laryngeal neoplasm. J. Med. Genet. 38:327.
2. Antonsson, A., O. Forslund, H. Ekberg, G. Sterner, and B. G. Hansson. 2000. The ubiquity and impressive genomic diversity of human papillomavirus suggest a commensalic nature of these viruses. J. Virol. 74:11636-11641.
3. Bregman, C. L., R. S. Hirth, J. P. Sundberg, and E. F. Christensen. 1987. Cutaneous neoplasms in dogs associated with canine oral papillomavirus vaccine. Vet. Pathol. 24:477-487.
4. Callan, M. B., D. Preziosi, and E. Mauldin. 2005. Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine. Vet. Dermatol. 16:338-345.
5. Chen, X. S., R. L. Garcea, I. Goldberg, G. Casini, and S. C. Harrison. 2000. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 5:557-567.
6. Coussens, L. M., D. Hanahan, and J. M. Arbeit. 1996. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol. 149:1899-1917.
7. Delius, H., M. A. Van Ranst, A. B. Jenson, H. zur Hausen, and J. P. Sundberg. 1994. Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology 204:447-452.
8. de Villiers, E.-M., C. Fauquet, T. R. Broker, H.-U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
9. Dillner, J. 1999. The serological response to papillomaviruses. Semin. Cancer Biol. 9:423-430.
10. Dunne, E. F., K. L. Karem, M. R. Sternberg, K. M. Stone, E. R. Unger, W. C. Reeves, and L. E. Markowitz. 2005. Seroprevalence of human papillomavirus type 16 in children. J. Infect. Dis. 191:1817-1819.
11. Ghim, S., J. Newsome, J. Bell, J. P. Sundberg, R. Schlegel, and A. B. Jenson. 2000. Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus. Exp. Mol. Pathol. 68:147-151.
12. Goldschmidt, M. H., J. S. Kennedy, D. R. Kennedy, H. Yuan, D. E. Holt, M. L. Casal, A. M. Traas, E. A. Mauldin, P. F. Moore, P. S. Henthorn, B. J. Hartnett, K. I. Weinberg, R. Schlegel, and P. J. Felsburg. 2006. Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J. Virol. 80:6621-6628.
13. Guan, M., H. Y. Chen, S. Y. Foo, Y. J. Tan, P. Y. Goh, and S. H. Wee. 2004. Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients. Clin. Diagn. Lab. Immunol. 11:287-291.
14. Harwood, C. A., and C. M. Proby. 2002. Human papillomaviruses and nonmelanoma skin cancer. Curr. Opin. Infect. Dis. 15:101-114.
15. Heim, K., A. Widschwendter, H. Szedenik, A. Geier, N. D. Christensen, A. Bergant, N. Concin, and R. Hopfl. 2005. Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions. Am. J. Obstet. Gynecol. 192:1073-1083.
16. Howley, P. M., and D. R. Lowy. 2001. Papillomaviruses and their replication, p. 2197-2264. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Baltimore, MD.
17. Hwang, G. Y., C. Y. Lin, L. M. Huang, Y. H. Wang, J. C. Wang, C. T. Hsu, S. S. Yang, and C. C. Wu. 2003. Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J. Clin. Microbiol. 41:5598-5603.
18. Jones, O. R., M. J. Crawley, J. G. Pilkington, and J. M. Pemberton. 2005. Predictors of early survival in Soay sheep: cohort-, maternal- and individual-level variation. Proc. Biol. Sci. 272:2619-2625.
19. Karem, K. L., A. C. Poon, C. Bierl, R. Nisenbaum, and E. Unger. 2002. Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 9:577-582.
20. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
21. Lillo, F. B. 2005. Human papillomavirus infection and its role in the genesis of dysplastic and neoplastic lesions of the squamous epithelia. New Microbiol. 28:111-118.
22. Liu, Q., L. Wang, P. Willson, B. O'Connor, J. Keenliside, M. Chirino-Trejo, R. Melendez, and L. Babiuk. 2002. Seroprevalence of porcine circovirus type 2 in swine populations in Canada and Costa Rica. Can. J. Vet. Res. 66:225-231.
23. Majewski, S., and S. Jablonska. 1995. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch. Dermatol. 131:1312-1318.
24. Marais, D. J., R. C. Rose, C. Lane, P. Kay, J. Nevin, L. Denny, R. Soeters, C. M. Dehaeck, and A.-L. Williamson. 2000. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia. J. Med. Virol. 60:403-410.
25. Marais, D. J., C. C. Sampson, M. I. Urban, F. Sitas, and A.-L. Williamson. 2007. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children. J. Med. Virol. 79:1370-1374.
26. Mitra, S., C. Misra, R. K. Singh, C. K. Panda, and S. Roychoudhury. 2005. Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J. Clin. Pathol. 58:26-31.
27. Morgenstern, H., and D. Thomas. 1993. Principles of study design in environmental epidemiology. Environ. Health Perspect. 101(Suppl. 4):23-38.
28. Nagata, M., H. Nanko, A. Moriyama, T. Washizu, and T. Ishida. 1995. Pigmented plaques associated with papillomavirus infection in dogs: is this epidermodysplasia verruciformis? Vet. Dermatol. 6:179-186.
29. Nöthling, J. O., D. Hussy, D. Steckler, and M. Ackermann. 2008. Seroprevalence of canine herpesvirus in breeding kennels in the Gauteng Province of South Africa. Theriogenology 69:276-282.
30. Pfister, H. 2003. Chapter 8: human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 2003:52-56.
31. Schwegler, K., J. H. Walter, and R. Rudolph. 1997. Epithelial neoplasms of the skin, the cutaneous mucosa and the transitional epithelium in dogs: an immunolocalization study for papillomavirus antigen. Zentralbl. Veterinaermed. A 44:115-123.
32. Scott, D. W., W. H. Miller, and C. E. Griffin. 2001. Viral, rickettsial and protozoal diseases, p. 517-542. In D. W. M. Scott, W. H. Miller, and C. E. Griffin (ed.), Muller & Kirk's small animal dermatology, 6th ed. W. B. Saunders, Philadelphia, PA.
33. Sehr, P., M. Muller, R. Hopfl, A. Widschwendter, and M. Pawlita. 2002. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J. Virol. Methods 106:61-70.
34. Sehr, P., K. Zumbach, and M. Pawlita. 2001. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J. Immunol. Methods 253:153-162.
35. Sterling, J. C. 2005. Human papillomaviruses and skin cancer. J. Clin. Virol. 32(Suppl. 1):S67-S71.
36. Stokking, L. B., E. J. Ehrhart, C. A. Lichtensteiger, and K. L. Campbell. 2004. Pigmented epidermal plaques in three dogs. J. Am. Anim. Hosp. Assoc. 40:411-417.
37. Stone, K. M., K. L. Karem, M. R. Sternberg, G. M. McQuillan, A. D. Poon, E. R. Unger, and W. C. Reeves. 2002. Seroprevalence of human papillomavirus type 16 infection in the United States. J. Infect. Dis. 186:1396-1402.
38. Sundberg, J. P., R. E. Junge, and W. D. Lancester. 1984. Immunoperoxidase localization of papillomaviruses in hyperplastic and neoplastic epithelial lesions in animals. Am. J. Vet. Res. 45:1441-1446.
39. Suzich, J. A., S. J. Ghim, F. J. Palmer-Hill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. B. Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557.
40. Teifke, J. P., C. V. Löhr, and H. Shirasawa. 1998. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization. Vet. Microbiol. 60:119-130.
41. Thrusfield, M. V. 2005. Demonstrating association, p. 247-265. In M. Thrusfield (ed.), Veterinary epidemiology, 3rd ed. Blackwell Publishing Professional, Ames, IA.
42. Tobler, K., C. Favrot, G. Nespeca, and M. Ackermann. 2006. Detection of the prototype of a potential novel genus in the family Papillomaviridae in association with canine epidermodysplasia verruciformis. J. Gen. Virol. 87:3551-3557.
43. Tobler, K., C. Lange, D. N. Carlotti, M. Ackermann, and C. Favrot. 2008. Detection of a novel papillomavirus in pigmented plaques of four pugs. Vet. Dermatol. 19:21-25.
44. Watrach, A. M., E. Small, and M. T. Case. 1970. Canine papilloma: progression of oral papilloma to carcinoma. J. Natl. Cancer Inst. 45:915-920.
45. Yuan, H., P. A. Estes, Y. Chen, J. Newsome, V. A. Olcese, R. L. Garcea, and R. Schlegel. 2001. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J. Virol. 75:7848-7853.
46. Yuan, H., S. Ghim, J. Newsome, T. Apolinario, V. Olcese, M. Martin, H. Delius, P. Felsburg, B. Jenson, and R. Schlegel. 2007. An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus. Virology 359:28-36.
47. Zaugg, N., G. Nespeca, B. Hauser, M. Ackermann, and C. Favrot. 2005. Detection of novel papillomaviruses in canine mucosal, cutaneous and in situ squamous cell carcinomas. Vet. Dermatol. 16:290-298.
48. zur Hausen, H. 1996. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-F78.